Corrects company ticker symbol in first bullet and header field
** Shares of investment management co Challenger CGF.AX drop as much as 8.8% to A$5.59, their lowest levels since January 28, 2022
** Co posts HY normalised NPAT of A$225 million ($142.94 million), lower than consensus estimate of A$229 million, according to Jefferies
** Total sales for co's core Life segment fall 12% in HY; Life normalised EBIT misses expectations
** Declares interim dividend of 14.5 Australian cents per share, higher than consensus estimates of 13.8 cents
** CGF stock is worst performer on ASX 200 benchmark index .AXJO
** Stock down 4.7% YTD, including day's moves
($1 = 1.5741 Australian dollars)
(Reporting by Himanshi Akhand in Bengaluru)
((Himanshi.Akhand@thomsonreuters.com;))
免责声明：投资有风险，本文并非投资建议，以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请，作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考，不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证，投资者应自行研究并在投资前寻求专业建议。